Cardiovascular Adverse Event Reporting in Psoriasis and Psoriatic Arthritis Biological Therapy Clinical Trials
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Wu J, Kavanaugh A, Lebwohl M, Gniadecki R, Merola J
. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2022; 36(6):797-806.
PMC: 9313585.
DOI: 10.1111/jdv.18044.
View
2.
Masson W, Lobo M, Molinero G
. Psoriasis and Cardiovascular Risk: A Comprehensive Review. Adv Ther. 2020; 37(5):2017-2033.
PMC: 7467489.
DOI: 10.1007/s12325-020-01346-6.
View
3.
Armstrong A, Read C
. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020; 323(19):1945-1960.
DOI: 10.1001/jama.2020.4006.
View
4.
Armstrong A, Mehta M, Schupp C, Gondo G, Bell S, Griffiths C
. Psoriasis Prevalence in Adults in the United States. JAMA Dermatol. 2021; 157(8):940-946.
PMC: 8246333.
DOI: 10.1001/jamadermatol.2021.2007.
View
5.
F Alexis A, Blackcloud P
. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. J Clin Aesthet Dermatol. 2014; 7(11):16-24.
PMC: 4255694.
View